As of November 2025, CNC's current EPS stands at -$10.75, according to the latest financial reports. Centene's EPS for 2024 amounted to $6.33, marking an increase from $4.97 in 2023. CNC reported an EPS of -$13.5 for the quarterly report ending on Sep 30, 2025.
For 2024, Centene's EPS was $6.33, an increase of 27.4% from $4.97 in 2023. The quarterly per-share earnings for the period ending Sep 30, 2025, was -$13.5, indicating a 1,085.4% decrease from the same quarter last year. CNC's 12-month EPS stands at -$10.75 as of September 2025. Centene's annual EPS in 2023 stood at $4.97, a 137.8% increase year-over-year.
Centene has registered a decrease in EPS of 1,085.4% during the last 12 months (YoY, quarterly). In the last three years, CNC recorded an average annual EPS growth rate of 39.9%. Centene had an average annual EPS growth rate of 14.7% during the last 5 years. Across the last decade, CNC had an average annual EPS growth of 18.4%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| MOH Molina Healthcare Inc | 9.21 | 8.5% | 21.6% | 11.6% |
| CI Cigna Corp | 11.43 | -30.3% | -8.3% | -2% |
| UNH Unitedhealth Group Inc | 16.86 | -35.2% | -5.2% | 1.5% |
| HUM Humana Inc | 19.55 | -50.2% | -24% | -13.1% |
| CNC Centene Corp | N/A | 27.4% | 39.9% | 14.7% |
All data is based on quarterly TTM periods, unless otherwise specified.